Author Archives: baldiesbuds

Alliance Growers Corp (CSE:ACG) is pleased to report vertically integrated additions to its revenue model and profit potential through expansion of its business partnership with Pharmagreen.  The two companies have agreed to the joint development of the proprietary high yield CBD DANA strain in a profitable industrial hemp operation that begins with tissue culture plantlets […]

Lexaria Bioscience Corp. (CSE:LXX,OTCQB:LXRP) (the “Company” or “Lexaria”) a drug delivery platform innovator, announces it has entered a definitive technology licensing agreement (the “Agreement”) with GP Holdings LLC. (“GP”) whereby Lexaria is providing its patented DehydraTECH(tm) technology to empower next-generation performance in high absorption, fast acting cannabis infused beverages to be developed and sold in California. GP […]

Nevada Organic Phosphate Inc. (“NOP” or the “Company”, formerly named Silver Eagle Mines Inc.) (CSE: NOP), a Nevada-based company engaged in the exploration for organic, sedimentary raw rock phosphate, is pleased to announce the appointment of Mr. Marco Montecinos as Project Manager to lead NOP’s development program at its Murdock Mountain property. Mr. Montecinos has […]

“The company is pleased to welcome a new group of investors, bolster the treasury and add to the companies working capital for future endeavours,” commented Beleave CEO Andrew Wnek. Each unit is comprised of one common share of the Company (a “Common Share”) and one-half of one common share purchase warrant of the Company (each whole […]

Cansortium Inc. CNTMF, a medical cannabis company that operates in Texas, said Friday it’s disappointed in the failure this week of two bills in the state legislature to expand medical marijuana in Texas. “For decades, cannabis prohibition has funneled thousands of Texans into the criminal justice system,” the company said. “With more than 80% of […]

Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI) (“Spectrum” or the “Company”), a biopharmaceutical Company focused on novel and targeted oncology announced today that on May 16, 2023, the Company received a written notification from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (Nasdaq) that the Company has regained compliance with the minimum bid […]

Sales License Health Canada has now completed its initial review of PureSinse’s Sales License application requesting an amendment to its Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license to add the activity of Sale of cannabis. PureSinse has confirmed with Health Canada it is now prepared to host an on-site the pre-Sales License inspection. PureSinse has established capabilities […]